The authors tested the Braunwald classification for its predictive validity for underlying coronary conditions, clinical courses, and responses to treatment. A reliable definition and classification of unstable angina is needed to help physicians make correct diagnoses of patients' conditions and to appraise findings from clinical trials critically. Many clinical trials have been conducted, but it is difficult to compare the results because of different entry criteria. Of 113 consecutive patients admitted with unstable angina, 89 who had primary angina were studied. Braunwald's classification was applied at admission. The outcomes of interest during hospitalization were coronary angiographic findings, short-term prognoses, and the treatment selected. Multivariate analysis showed that the severity class expressed significant positive predictivity for coronary thrombi (adjusted odds ratio [OR], 6.53; 95% confidence interval [CI], 2.82 to 15.1) and progress to impending infarction (OR, 10.43; CI, 3.35 to 32.49). The treatment (OR, 0.02; CI, 0.004 to 0.08) and electrocardiographic (OR, 0.22; CI 0.10 to 0.49) classes showed independent negative predictivity for coronary vasospasm. The treatment (OR, 3.50; CI, 1.94 to 6.33) and electrocardiographic (odds ratio, 3.27; CI, 1.87 to 5.71) classes showed positive predictivity for the necessity for recanalization treatment with coronary angioplasty or bypass grafting. The Braunwald classification used at admission is highly predictive of underlying coronary conditions, progression to impending infarction, and the final selection of treatment. This classification should be considered in determining patient eligibility in clinical trials and studies.

Download full-text PDF

Source
http://dx.doi.org/10.1177/000331979704800801DOI Listing

Publication Analysis

Top Keywords

braunwald classification
12
unstable angina
12
clinical trials
12
predictive validity
8
classification unstable
8
angiographic findings
8
findings short-term
8
short-term prognoses
8
prognoses treatment
8
underlying coronary
8

Similar Publications

Storytelling of Hypertrophic Cardiomyopathy Discovery.

J Cardiovasc Dev Dis

September 2024

Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, 35121 Padova, Italy.

Article Synopsis
  • The discovery of hypertrophic cardiomyopathy (HCM) began in 1958 when Donald Teare noted cases of asymmetric ventricular septum hypertrophy during autopsies, linking sudden deaths to this condition.
  • The term "idiopathic hypertrophic subaortic stenosis" emerged in the late 1950s and highlighted the confusion between HCM and valve-related issues, as seen in cases managed by Eugene Braunwald and Andrew Glenn Morrow.
  • Over the decades, HCM has been classified and better understood, evolving from early notions of "functional subaortic stenosis" to a formal classification of cardiomyopathies established by John F. Goodwin and refined by the WHO, recognizing familial links and new types
View Article and Find Full Text PDF

Novel Polygenic Risk Score and Established Clinical Risk Factors for Risk Estimation of Aortic Stenosis.

JAMA Cardiol

April 2024

Cardiovascular Medicine Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Article Synopsis
  • A study was conducted to develop a polygenic risk score (PRS) specifically for aortic stenosis and compare its effectiveness against traditional clinical risk factors.
  • This research involved analyzing data from large cohorts, including over 135,000 participants from the Million Veteran Program and various clinical trials between 2011 and 2020.
  • The findings indicated that the new aortic stenosis PRS, which utilized millions of genetic variants, may provide significant risk estimation for the condition compared to established clinical methods.
View Article and Find Full Text PDF

Predicting radiocephalic arteriovenous fistula success with machine learning.

NPJ Digit Med

October 2022

Division of Vascular and Endovascular Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

After creation of a new arteriovenous fistula (AVF), assessment of readiness for use is an important clinical task. Accurate prediction of successful use is challenging, and augmentation of the physical exam with ultrasound has become routine. Herein, we propose a point-of-care tool based on machine learning to enhance prediction of successful unassisted radiocephalic arteriovenous fistula (AVF) use.

View Article and Find Full Text PDF

Mortality and Heart Failure Hospitalization Among Young Adults With and Without Cardiogenic Shock After Acute Myocardial Infarction.

J Card Fail

January 2023

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

Objectives: To investigate risk factors and outcomes of cardiogenic shock complicating acute myocardial infarction (AMI-CS) in young patients with AMI.

Background: AMI-CS is associated with high morbidity and mortality rates. Data regarding AMI-CS in younger individuals are limited.

View Article and Find Full Text PDF

Aim: The win ratio can incorporate different types of outcomes and enhance statistical power, making it a useful method for analysing composite outcomes in cardiovascular trials. The application of this approach to the PARADISE-MI trial provides an additional perspective into understanding the effects of sacubitril/valsartan in patients with acute myocardial infarction.

Methods And Results: We conducted a post-hoc analysis of the PARADISE-MI trial, which randomly assigned patients with acute myocardial infarction complicated by a reduced left ventricular ejection fraction, pulmonary congestion, or both to receive either sacubitril/valsartan (97 mg of sacubitril and 103 mg of valsartan twice daily) or ramipril (5 mg twice daily) in addition to guideline-recommended therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!